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use#LAAResearch has suggested that lead toxicity may
disproportionately affect minority groups.
(Bailey et al. 1994; Rothenberg et al. 1999).
Despite substantial declines in blood lead
levels in the general U.S. population, a sub-
stantial body of research, including data from
the Third National Health and Nutrition
Examination Survey (NHANES III), shows
that African Americans continue to have
higher blood lead levels than do whites (Brody
et al. 1994; Lanphear et al. 1996; Mahaffey
et al. 1982; Pirkle et al. 1998).
Most studies analyzing racial differences
in lead toxicity have focused on blood lead
as a biomarker. Although blood lead mostly
provides an accurate measure of recent lead
exposure, evidence has been growing to
indicate that this biomarker does not ade-
quately reflect an individual’s health risk
due to cumulative lead exposure (Hu et al.
1998). In adults, about 95% of the total
body lead burden is stored in the skeleton
(Barry and Mossman 1970), and the half-
life of lead in bone ranges from years to
decades (Rabinowitz 1991). With a half-life
of up to 25 years (Rabinowitz et al. 1976),
bone lead is a biologic marker of cumulative
lead exposure over many years and may bet-
ter predict the effects of lead toxicity that
arise from chronic low to moderate expo-
sure, such as hypertension (Cheng et al.
2001; Glenn et al. 2003; Hu et al. 1996a;
Korrick et al. 1999; Lee et al. 2001). 
Sociodemographic rather than genetic fac-
tors, including low income and residence in
older housing, have been attributed to the
higher blood lead levels seen in black children
(Pirkle et al. 1998). Although low income and
education have also been correlated with
higher blood and bone lead levels among white
males (Elreedy et al. 1999; Hu et al. 1996b),
minority groups are disproportionately
affected. In recent data from the Normative
Aging Study, nonwhite blue-collar workers
had signiﬁcantly higher blood and patella lead
did than white blue-collar workers, suggesting
an interaction between occupational exposures
and race/ethnicity (Elmarsafawy et al. 2002).
However, the generalizability of this study is
limited by its size, because nonwhites com-
prised < 2% of the total sample population.
To build on this work, in the Community
Lead Study we focused on analyzing the bone
lead levels of an exclusively minority sample.
Materials and Methods
Study subjects. Subjects were recruited from the
pool of subjects who participated in a study
funded by the National Institutes of Health
(NIH; “Impact of Sleep-Disordered Breathing
in Older Adults,” NIH HL51075; principal
investigator, D. Sparrow; 1 July 1994–30 June
1997) that had signiﬁcant minority and female
involvement. These subjects had been initially
recruited via solicitation letters sent to residents
in Boston, Massachusetts, census tracts in the
Jamaica Plain neighborhood with high
minority representation. Additional subjects
for our study were drawn from the Roxbury,
Dorchester, and Jamaica Plain neighbor-
hoods—which also have high minority repre-
sentation—through participant referrals to
family members and friends.
Letters introducing the study and demo-
graphic and consent forms were sent to poten-
tial subjects. Only minority subjects ≥ 35 years
of age were accepted. Willing and eligible par-
ticipants were invited to the Brigham and
Women’s Hospital outpatient clinic in
Boston, where a fresh whole blood specimen
was collected for lead measurement and
where K X-ray fluorescence (KXRF) bone
lead measurements were taken. Blood and
bone lead measurements were taken between
1999 and 2000 for participating subjects.
Participants who completed the study were
reimbursed for their time and effort.
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We measured blood and bone lead levels among minority individuals who live in some of Boston’s
neighborhoods with high minority representation. Compared with samples of predominantly white
subjects we had studied before, the 84 volunteers in this study (33:67 male:female ratio;
31–72 years of age) had similar educational, occupational, and smoking proﬁles and mean blood,
tibia, and patella lead levels (3 µg/dL, 11.9 µg/g, and 14.2 µg/g, respectively) that were also similar.
The slopes of the univariate regressions of blood, tibia, and patella lead versus age were
0.10 µg/dL/year (p < 0.001), 0.45 µg/g/year (p < 0.001), and 0.73 µg/g/year (p < 0.001), respec-
tively. Analyses of smoothing curves and regression lines for tibia and patella lead suggested an
inﬂection point at 55 years of age, with slopes for subjects ≥ 55 years of age that were not only
steeper than those of younger subjects but also substantially steeper than those observed for indi-
viduals > 55 years of age in studies of predominantly white participants. This apparent racial dis-
parity at older ages may be related to differences in historic occupational and/or environmental
exposures, or possibly the lower rates of bone turnover that are known to occur in postmenopausal
black women. The higher levels of lead accumulation seen in this age group are of concern because
such levels have been shown in other studies to predict elevated risks of chronic disease such as
hypertension and cognitive dysfunction. Additional research on bone lead levels in minorities and
their socioeconomic and racial determinants is needed. Key words: blacks, blood lead, bone lead,
minority groups, occupations, smoking, X-ray fluorescence. Environ Health Perspect
112:1147–1151 (2004). doi:10.1289/ehp.6705 available via http://dx.doi.org/ [Online 3 May 2004]
Research ArticleCenter in Boston approved the research pro-
ject. Written informed consent was obtained
from all participants.
Blood lead measurement. Blood for lead
measurements was collected in 7-mL trace-
metal–free tubes (Becton-Dickinson Co.,
Bedford, MA) containing EDTA and sent for
analysis to ESA Laboratories, Inc. (Chelmsford,
MA). The ESA Laboratories blood lead analy-
sis protocol and quality control and quality
assurance speciﬁcations are described elsewhere
(Hu et al. 1996b).
KXRF bone lead measurement. An
ABIOMED KXRF instrument (ABIOMED,
Inc., Danvers, MA) was used to take bone lead
measurements of each subject’s midtibial shaft
and patella. The physical principles, technical
speciﬁcations, validation, and quality control
procedures of this (Burger et al. 1990; Hu
et al. 1990, 1994) and similar KXRF instru-
ments (Ellis et al. 1987; Somervaille et al.
1985) have been described in detail elsewhere.
Briefly, KXRF uses a 109Cd gamma-ray
source to induce ﬂuorescence from the target
tissue. The emitted photons are then
detected, counted, and arrayed on a spectrum
(Hu et al. 1989). The net lead signal is deter-
mined after Compton background counts are
subtracted by a linear least-squares algorithm.
For each subject, 30-min measurements
were taken at the midshaft of the tibia and
patella after each region had been washed
with a 70% solution of isopropyl alcohol.
The KXRF beam collimator was sited perpen-
dicular to the flat bone surface for the tibia
and patella.
Statistical analyses. We used Stata version
7.0 (Stata Corporation, College Station, TX)
and S-Plus version 6.1 (Insightful Corporation,
Seattle, WA) for database management and sta-
tistical analysis. The quality of the KXRF mea-
surements was preserved by discarding tibia and
patella lead values with associated measure-
ment-uncertainty estimates of > 10 µg/g and
>1 5µg/g, respectively. Negative tibia and
patella measurements were retained to mini-
mize bias and increase efﬁciency of comparing
bone lead levels among different populations
(Kim et al. 1995).
We created ﬁnal education categories after
collapsing comparable educational levels that
had similar blood and bone lead data. Subjects
with technical school training and college edu-
cation were pooled together, as were students
with graduate and professional schooling. For
race, the 69 black participants comprised one
category and the 15 other subjects, who were
Hispanic, Asian, and American Indian, were
classified as “other.” For job type, we classi-
fied retired subjects as white collar or blue
collar based on their previous occupation. For
example, doctors, lawyers, engineers, and so
on, were categorized as white collar, whereas
technicians, repairmen, carpenters, and so
forth, were categorized as blue collar. We
adopted a complete classification list of pro-
fessions which has been published elsewhere
by Elmarsafawy et al. (2002).
We examined blood, patella, and tibia lead
levels across categories of age, race, education,
smoking status, alcohol consumption, and job
type. Simple linear regression of blood, tibia,
and patella lead level versus age was performed
over the entire age range. We performed
graphic evaluation by locally weighted scatter
plot smoothing (Lowess) to verify and select an
inflection point for both biomarkers
(Cleveland et al. 1976). Separate regression
analyses were performed on subjects younger
and older than this cutoff point, and male and
female data were analyzed separately and
together.
Multiple linear regression models were
constructed to predict blood, tibia, and
patella lead. Age, sex, race, educational level,
alcohol consumption, cumulative smoking,
and job type—variables known to be associ-
ated with these biomarkers—were forced into
all models. Interaction terms of black race
with blue-collar work, black race with male
sex, and male sex with blue-collar work were
tested for signiﬁcance.
Results
A total of 108 subjects participated in this
study, coming from the Jamaica Plain,
Roxbury, and Dorchester neighborhoods in
Boston: 86 black, 7 Hispanic, 3 American
Indian, 2 Asian, and 10 other or unknown.
Response rates to mailings in the parent study
(< 10%) and the present study (< 10%) made
our sample largely one of convenience. A ﬁnal
population of 84 subjects were included in the
present analyses after we excluded 14 subjects
for tibia (n = 13) and patella (n = 1) lead values
associated with measurement uncertainty esti-
mates of > 10 µg/g and > 15 µg/g, respectively,
and 10 subjects who were missing covariate
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Table 1. Lead biomarker levels (mean ± SD) among Community Lead Study subgroups, Boston, Massachusetts, 1999–2000.
Age-adjusted Age-adjusted
Blood lead Tibia lead tibia lead Patella lead patella lead
Variable No. (µg/dL) (µg/g) (µg/g) (µg/g) (µg/g)
Age (years)
< 45 28 2.0 ± 1.2 8.3 ± 8.4 8.9 ± 14.3
46–60 41 2.8 ± 1.7 10.8 ± 11.5 11.8 ± 11.4
61–75 15 5.3 ± 3.2# 21.7 ± 8.6# 30.9 ± 15.7#
Sex
Female 56 2.7 ± 2.2 11.8 ± 11.9 12.0 ± 11.0 13.8 ± 15.0 14.1 ± 13.5
Male 28 3.6 ± 2.2* 12.1 ± 9.0 11.7 ± 7.9 15.0 ± 16.1 14.3 ± 13.3
Race
Black 69 3.0 ± 2.3 12.9 ± 11.2 12.7 ± 10.4 14.6 ± 15.4 14.4 ± 12.9
Other 15 2.9 ± 2.0 7.3 ± 8.8* 7.9* ± 7.2 12.3 ± 14.9 13.3 ± 15.9
Education
High school dropout 14 2.6 ± 2.2 9.4 ± 6.3 11.3 ± 7.4 12.9 ± 10.0 16.0 ± 10.1
High school graduate 26 3.6 ± 2.9 13.7 ± 12.9 12.9 ± 10.8 16.9 ± 20.3 15.7 ± 16.4
Technical school, college  31 2.7 ± 1.4 10.8 ± 9.2 10.8 ± 8.9 12.2 ± 12.0 12.2 ± 11.0
Graduate school, professional 13 3.0 ± 2.1 13.6 ± 14.8 13.0 ± 13.8 15.2 ± 16.0 14.1 ± 15.8
Smoking (pack-years)
03 62 .7 ± 1.9 9.9 ± 11.1 9.9 ± 11.0 12.7 ± 14.9 12.7 ± 14.6
1–19 38 3.0 ± 2.1 11.9 ± 10.3 12.4 ± 8.7 12.5 ± 14.4 13.3 ± 11.5
≥ 20  10 4.1 ± 3.3 19.2 ± 11.3* 17.5 ± 9.5* 26.0 ± 16.1** 23.2 ± 13.1*
Consuming ≥ 2 alcoholic drinks/day
No 78 2.9 ± 2.2 12.0 ± 11.2 11.9 ± 10.2 14.0 ± 15.6 13.8 ± 13.6
Yes 6 3.7 ± 2.5 10.0 ± 7.9 12.0 ± 8.9 16.3 ± 11.3 19.5 ± 9.8
Job type
White collar/mixed 56 2.8 ± 2.1 11.3 ± 11.7 11.1 ± 10.9 12.0 ± 15.3 11.8 ± 13.3
Blue collar 28 3.4 ± 2.3 13.1 ± 9.6 13.4 ± 8.1 18.6 ± 14.5* 19.1 ± 12.5**
*p < 0.1, **p < 0.05, and #p < 0.01 by analysis of variance.values for education (n = 6) and/or job type
(n = 4). Comparisons between the 84 included
subjects and 24 excluded subjects revealed no
meaningful differences with regard to blood,
tibia, or patella lead or age, race, education,
pack-years of smoking, alcohol consumption,
or job type.
Our sample of 84 subjects had a mean age
of 50 years (range, 31–77 years), and 56 (67%)
subjects were female (Table 1). The propor-
tions of subjects whose education was limited
to high school or lower (48%), who had a his-
tory of smoking (57%), and who worked in
blue-collar jobs (33%) were not too dissimilar
from the proportions we observed among the
predominantly white subjects participating in
the Normative Aging Study (47, 68, and 41%,
respectively; Hu et al. 1996b; Elmarsafawy
et al. 2002).
The mean and median blood lead levels of
the present sample of 84 subjects were
3.0 µg/dL and 2.2 µg/dL, respectively. The
mean ± SD for tibia lead was 11.9 ± 11.0 µg/g,
and for patella lead, 14.2 ± 15.3 µg/g. In sim-
ple regression models, the slope coefﬁcients of
blood lead, and patella lead versus age were
0.10 µg/dL/year (p < 0.001), 0.45 µg/g/year
(p < 0.001), and 0.73 µg/g/year (p < 0.001),
respectively. Further analysis with smooth-
ing plots indicated that the associations
between age and bone lead biomarkers were
nonlinear. In general, the univariate regres-
sion slopes of tibia and patella lead versus
age were greater among subjects ≥ 55 years
of age than among those < 55 years of age
(Figures 1–3). A simple linear regression of
patella lead versus age followed an average
slope of 0.2 µg/g/year up to 55 years and
then inflected upward to increase at
0.83 µg/g/year in subjects ≥ 55 years of age
(data not shown). Likewise, tibia lead
increased at a rate of 0.15 µg/g/year in partic-
ipants < 55 years of age and at a rate of 0.69
µg/g/year ≥ 55 years of age (Figure 4). The
differences in regression coefﬁcients between
the two age groups were statistically signifi-
cant. Because of limited published data on
patella lead, only the regression coefficients
of tibia lead are compared with those
observed in other studies in Figure 4 (Hu
et al. 1990; Hu et al. 1996b; Kosnett et al.
1994; Roy et al. 1997).
For blood and patella lead, males and
females < 55 years of age had similar rates of
lead accumulation with increasing age; in con-
trast, among subjects ≥ 55 years of age, males
had higher rates of accumulation. For tibia
lead, a similar trend was observed, but the dis-
parity among those ≥ 55 years was smaller.
In multiple regression models with inde-
pendent variables that included age, sex, race,
pack-years of smoking, drinking, educational
levels, and occupation, age was the most sig-
niﬁcant predictor for blood, tibia, and patella
lead (Table 2). A history of smoking > 20
pack-years predicted a 7.2 µg/g/year increase
in tibia lead with borderline significance
(p < 0.10). Having a blue-collar occupation
signiﬁcantly predicted an 8.02 µg/g increase in
patella lead (p < 0.05). When interaction
terms between black race and blue-collar
work, black race and male sex, and male sex
and blue-collar occupation were tested as pre-
dictors of lead biomarkers, they were insigniﬁ-
cant (data not shown).
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Figure 1. Scatter plots and smoothed lines of blood lead levels (n = 84) versus
age in community-exposed minority subjects, Community Lead Study, Boston,
Massachusetts, 1999–2000.
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Figure 2. Scatter plots and smoothed lines of tibia lead levels (n = 84) versus
age in community-exposed minority subjects, Community Lead Study, Boston,
Massachusetts, 1999–2000.
60
40
20
0
–20
Age (years)
T
i
b
i
a
 
l
e
a
d
 
(
µ
g
/
g
)
Combined
Female, ●
Male, ▲
30 40 50 60 70 80
Figure 4. Comparison of regression lines of tibia bone lead versus age between
community-exposed minority subjects from the Community Lead Study, Boston,
Massachusetts, 1999–2000, and other studies of predominantly white participants.
30
25
20
15
10
5
0
T
i
b
i
a
 
l
e
a
d
 
(
µ
g
/
g
)
Age (years)
01 0 2 03 0 4 05 0 6 07 0 8 0
CLS < 55 years Y = 0.15x + 2.55
CLS ≥ 55 years Y = 0.69x – 25.05
Hu et al. (1996b) Y = 0.38x – 4.58
Kosnett et al. (1994) Y = 0.38x – 7.6
Hu et al. (1990) Y = 0.31x – 6.71
Roy et al. (1997) Y = 0.244x – 0.62
Figure 3. Scatter plots and smoothed lines of patella lead levels (n = 84) versus
age in community-exposed minority subjects, Community Lead Study, Boston,
Massachusetts, 1999–2000.
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The blood and bone lead levels we observed in
this study indicate that this minority sample
had lead exposure similar to that of the general
population. The relatively low levels of blood
lead (mean, 3.0 µg/dL) parallel those reported
for individuals 20–74 years of age in the
1988–1991 NHANES III (mean, 3.0 µg/dL)
(Pirkle et al. 1994). Studies of community-
exposed, predominantly white subjects of
similar age had tibia lead levels (Gamblin
et al. 1994; Kosnett et al. 1994; Somervaille
et al. 1988) and patella lead levels (Korrick
et al. 2002) comparable with those observed
in this study.
As seen in other studies of general popula-
tion samples, age was the predominate corre-
late of tibia lead (Gamblin et al. 1994; Kosnett
et al. 1994; McNeill et al. 2000) and patella
lead (Hu et al. 1996b; Korrick et al. 2002),
accounting for nearly half of the variability in
multivariate regressions of both biomarkers.
The strong association between age and bone
lead probably reﬂects exposure to different lev-
els of environmental lead over time, that is, the
birth cohort effect previously reported (Kim
et al. 1997). Univariate smoothing curves and
simple regression models of tibia and patella
lead versus age showed a smaller slope among
subjects < 55 years of age, an inﬂection point at
55 years, and a greater slope at ≥ 55 years
(Figures 2 and 3). These results may reﬂect a
trend similar to that observed previously for
tibia lead among community-exposed white
men (Kosnett et al. 1994). We did not attempt
a nonlinear model, which would likely have
overﬁtted data from our small sample size.
Compared with age-related increases in
bone lead of β = 0.31 µg/g/year observed by
Hu et al. (1990) and β = 0.38 µg/g/year
observed by Kosnett et al. (1994), tibia lead in
our study increased at a lower rate (β =
0.15 µg/g/year) for subjects < 55 years of age.
This discrepancy may be due to the differences
in age range among these three studies. Study
subjects from both the Hu et al. (1990) and
Kosnett et al. (1994) studies, with ranges of
21–58 years and 20–55 years, respectively,
spanned a wider age range, including younger
individuals in their third decade with higher
growth and bone formation rates.
In contrast, among subjects ≥ 55 years of
age, tibia lead increased at a greater rate (β =
0.69 µg/g/year) than that measured in previ-
ous Normative Aging Study research (β =
0.38 µg/g/year; Hu et al. 1996b) (Figure 4).
It is possible that genetic differences in bone
turnover account for some of the observed dis-
crepancy in those subjects ≥ 55 years of age.
Two studies (Aloia et al. 1998; Luckey et al.
1996) have shown that postmenopausal black
women have lower rates of bone turnover than
do postmenopausal white women. Decreased
formation of new bone in a more recent
lower-lead environment would result in higher
relative bone lead levels. The fact that women
comprise two-thirds of our subjects may
explain why the tibia lead accumulation rate
in subjects ≥ 55 years of age was higher than
that observed elsewhere (Hu et al. 1996b).
The steeper bone lead–age relationship in
older individuals may also be due to increased
environmental exposures among retirees.
Boston’s prevalence of old housing has been
tied to greater lead exposure via dust inhala-
tion from lead paint in children (Bailey et al.
1994) and via ingestion of water contami-
nated from lead plumbing in adults (Potula
et al. 1999). Housing age and lead amounts
in tap water were not measured in this study,
but given the fact that approximately 50% of
housing in Boston was built before 1950
(Massachusetts Department of Public Health
1999), it seems likely that retirees who spend
more time at home are at increased risk for
environmental lead exposure.
When analyzed by sex, males exhibited a
higher rate of blood and patella lead
accumulation among subjects ≥ 55 years of
age. This sex-related difference may be due to
increased bone remodeling in postmenopausal
women, supporting a trend previously
reported by Hertz-Picciotto et al. (2000) and
Rothenberg et al. (1994). As old bone is
replaced by new bone matrix formed in a
more recent lower-lead environment, women
may experience a relative decrease in bone lead
concentration. The same trend is blunted in
tibia lead and reﬂects its lower bone turnover
rate and thus decreased sensitivity to the onset
of menopause.
Although participants were not asked if
they had occupational lead exposure, in multi-
variate analyses blue-collar work by itself was a
significant determinant of patella lead
(p < 0.05). In previous research of a sample of
white men who were not employed in lead-
related industries, we found that tibia and
patella lead levels were higher in those
employed in blue-collar jobs (Elmarsafawy
et al. 2002). Because the same classification
criteria for white-collar and blue-collar jobs
were used in this study, this analysis provides
some support that occupational lead exposure
is a risk factor for these minority individuals.
Unlike our ﬁndings in the Normative Aging
Study (Hu et al. 1996b), low education was
not a significant predictor of blood or bone
lead; however, individuals in our sample were
relatively well educated, with > 50% having
had some college education and two-thirds
working in white-collar jobs, which may have
limited our ability to discern the influence
education as a proxy of social class.
The main limitations of this study stem
from our relatively limited sample size as well
as potential biases related to our subject
recruitment. Although our subjects came from
some of Boston’s high-minority-representation
communities, they were volunteers who had
participated in previous research and who
essentially comprised a convenience sample. In
addition, our models of bone lead were only
able to explain up to 24% of their variance—a
figure that is similar to those found in other
studies such as the Normative Aging Study
(Hu et al. 1996b); thus, there are likely many
unmeasured factors that could explain differ-
ences in bone lead distributions. Nevertheless,
comparisons of our data with those from the
predominantly white subjects participating in
the Normative Aging Study and other popula-
tions is instructive, particularly because their
distributions of the main factors determined
to be predictors of bone lead in the general
population—education, smoking, and occu-
pational status—are similar. In so doing, our
finding of tibia bone lead levels in subjects
>5 5years of age that were higher than those
seen in whites of similar age is concerning
because elevated bone lead levels have been
clearly implicated as a risk factor for chronic
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Table 2. Multiple regression of lead biomarker levels in the Community Lead Study, Boston, Massachusetts,
1999–2000.
Blood lead (µg/dL) Tibia lead (µg/g) Patella lead (µg/g)
Characteristic β 95% CI β 95% CI β 95% CI
Age (years) 0.10 0.05–0.14 0.42 0.19–0.65 0.72 0.42–1.02
Male sex 0.59 –0.46–1.65 –1.75 –7.13–3.63 –4.04 –11.08–3.00
Black racea –0.11 –1.28–1.07 4.04 –1.92–10.00 –0.29 –8.09–7.51
Educationb
High school graduate 0.56 –0.92–2.03 –0.52 –8.03–7.00 –0.17 –9.99–9.66
Technical school, college 0.07 –1.35–1.50 –0.82 –8.08–6.44 –1.40 –10.90–8.10
Graduate school, professional 0.16 –1.47–1.78 2.04 –6.23–10.32 0.38 –10.45–11.21
Smoking (pack-years)c
0–20 0.10 –0.89– 1.09 2.67 –2.37–7.72 –0.53 –7.13–6.07
≥ 20 0.52 –1.07–2.11 7.18 –0.92–15.29 8.62 –1.98–19.22
Currently consuming  0.97 –0.85–2.80 –1.41 –10.72–7.90 1.12 –11.06–13.31
≥ 2 alcoholic drinks/day
Blue-collar occupationd 0.22 –0.92–1.35 2.10 –3.67–7.87 8.02 0.47–15.58
Total model adjusted R2 0.18 0.15 0.24
CI, conﬁdence interval.
aCompared with other minorities. bBaseline: high school dropout. cCompared with 0 pack-years of smoking. dCompared
with white-collar occupations.disease such as hypertension (Cheng et al.
2001; Glenn et al. 2003; Hu et al. 1996a;
Korrick et al. 1999; Lee et al. 2001). Clearly,
more research is needed to examine bone and
blood lead levels in minority groups, with an
increased emphasis on those who may have
lower educational and occupational status and
who may therefore be at greatest risk for
chronic lead exposure and its impact on health.
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